The Establishment and Diversification of Epidemic-Associated Serogroup W Meningococcus in the African Meningitis Belt, 1994 to 2012
- PMID: 27904879
- PMCID: PMC5112335
- DOI: 10.1128/mSphere.00201-16
The Establishment and Diversification of Epidemic-Associated Serogroup W Meningococcus in the African Meningitis Belt, 1994 to 2012
Abstract
Epidemics of invasive meningococcal disease (IMD) caused by meningococcal serogroup A have been eliminated from the sub-Saharan African so-called "meningitis belt" by the meningococcal A conjugate vaccine (MACV), and yet, other serogroups continue to cause epidemics. Neisseria meningitidis serogroup W remains a major cause of disease in the region, with most isolates belonging to clonal complex 11 (CC11). Here, the genetic variation within and between epidemic-associated strains was assessed by sequencing the genomes of 92 N. meningitidis serogroup W isolates collected between 1994 and 2012 from both sporadic and epidemic IMD cases, 85 being from selected meningitis belt countries. The sequenced isolates belonged to either CC175 (n = 9) or CC11 (n = 83). The CC11 N. meningitidis serogroup W isolates belonged to a single lineage comprising four major phylogenetic subclades. Separate CC11 N. meningitidis serogroup W subclades were associated with the 2002 and 2012 Burkina Faso epidemics. The subclade associated with the 2012 epidemic included isolates found in Burkina Faso and Mali during 2011 and 2012, which descended from a strain very similar to the Hajj (Islamic pilgrimage to Mecca)-related Saudi Arabian outbreak strain from 2000. The phylogeny of isolates from 2012 reflected their geographic origin within Burkina Faso, with isolates from the Malian border region being closely related to the isolates from Mali. Evidence of ongoing evolution, international transmission, and strain replacement stresses the importance of maintaining N. meningitidis surveillance in Africa following the MACV implementation. IMPORTANCE Meningococcal disease (meningitis and bloodstream infections) threatens millions of people across the meningitis belt of sub-Saharan Africa. A vaccine introduced in 2010 protects against Africa's then-most common cause of meningococcal disease, N. meningitidis serogroup A. However, other serogroups continue to cause epidemics in the region-including serogroup W. The rapid identification of strains that have been associated with prior outbreaks can improve the assessment of outbreak risk and enable timely preparation of public health responses, including vaccination. Phylogenetic analysis of newly sequenced serogroup W strains isolated from 1994 to 2012 identified two groups of strains linked to large epidemics in Burkina Faso, one being descended from a strain that caused an outbreak during the Hajj pilgrimage in 2000. We find that applying whole-genome sequencing to meningococcal disease surveillance collections improves the discrimination among strains, even within a single nation-wide epidemic, which can be used to better understand pathogen spread.
Keywords: Africa; Neisseria meningitidis; disease outbreaks; epidemiology; evolution; meningitis; meningococcus.
Figures



Similar articles
-
Molecular characterization of invasive meningococcal isolates in Burkina Faso as the relative importance of serogroups X and W increases, 2008-2012.BMC Infect Dis. 2018 Jul 18;18(1):337. doi: 10.1186/s12879-018-3247-x. BMC Infect Dis. 2018. PMID: 30021533 Free PMC article.
-
Phylogenetic relationships and regional spread of meningococcal strains in the meningitis belt, 2011-2016.EBioMedicine. 2019 Mar;41:488-496. doi: 10.1016/j.ebiom.2019.02.054. Epub 2019 Mar 4. EBioMedicine. 2019. PMID: 30846392 Free PMC article.
-
Molecular insights into meningococcal carriage isolates from Burkina Faso 7 years after introduction of a serogroup A meningococcal conjugate vaccine.Microb Genom. 2020 Dec;6(12):mgen000486. doi: 10.1099/mgen.0.000486. Epub 2020 Dec 11. Microb Genom. 2020. PMID: 33332261 Free PMC article.
-
Global epidemiology of capsular group W meningococcal disease (1970-2015): Multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex.Vaccine. 2016 Mar 18;34(13):1515-1523. doi: 10.1016/j.vaccine.2016.02.014. Epub 2016 Feb 12. Vaccine. 2016. PMID: 26876439 Review.
-
Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.Vaccine. 2013 Jun 12;31(27):2852-61. doi: 10.1016/j.vaccine.2013.04.036. Epub 2013 Apr 24. Vaccine. 2013. PMID: 23623866 Review.
Cited by
-
Insights on Population Structure and Within-Host Genetic Changes among Meningococcal Carriage Isolates from U.S. Universities.mSphere. 2020 Apr 8;5(2):e00197-20. doi: 10.1128/mSphere.00197-20. mSphere. 2020. PMID: 32269159 Free PMC article.
-
Epidemiology of Bacterial Meningitis in the Nine Years Since Meningococcal Serogroup A Conjugate Vaccine Introduction, Niger, 2010-2018.J Infect Dis. 2019 Oct 31;220(220 Suppl 4):S206-S215. doi: 10.1093/infdis/jiz296. J Infect Dis. 2019. PMID: 31671439 Free PMC article.
-
The Bacterial Meningitis Epidemic in Banalia in the Democratic Republic of Congo in 2021.Vaccines (Basel). 2024 Apr 25;12(5):461. doi: 10.3390/vaccines12050461. Vaccines (Basel). 2024. PMID: 38793712 Free PMC article.
-
Neisseria genomics: current status and future perspectives.Pathog Dis. 2017 Aug 31;75(6):ftx060. doi: 10.1093/femspd/ftx060. Pathog Dis. 2017. PMID: 28591853 Free PMC article. Review.
-
Whole genome sequencing for investigations of meningococcal outbreaks in the United States: a retrospective analysis.Sci Rep. 2018 Oct 25;8(1):15803. doi: 10.1038/s41598-018-33622-5. Sci Rep. 2018. PMID: 30361650 Free PMC article.
References
-
- Novak RT, Kambou JL, Diomandé FV, Tarbangdo TF, Ouédraogo-Traoré R, Sangaré L, Lingani C, Martin SW, Hatcher C, Mayer LW, Laforce FM, Avokey F, Djingarey MH, Messonnier NE, Tiendrébéogo SR, Clark TA. 2012. Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. Lancet Infect Dis 12:757–764. doi:10.1016/S1473-3099(12)70168-8. - DOI - PMC - PubMed
-
- Daugla DM, Gami JP, Gamougam K, Naibei N, Mbainadji L, Narbé M, Toralta J, Kodbesse B, Ngadoua C, Coldiron ME, Fermon F, Page AL, Djingarey MH, Hugonnet S, Harrison OB, Rebbetts LS, Tekletsion Y, Watkins ER, Hill D, Caugant DA, Chandramohan D, Hassan-King M, Manigart O, Nascimento M, Woukeu A, Trotter C, Stuart JM, Maiden MC, Greenwood BM. 2014. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study. Lancet 383:40–47. doi:10.1016/S0140-6736(13)61612-8. - DOI - PMC - PubMed
-
- World Health Organization 2015. Meningococcal disease control in countries of the African meningitis belt, 2014. Wkly Epidemiol Rec 90:123–131. http://www.who.int/wer/2015/wer9013.pdf?ua=1. - PubMed
-
- Lingappa JR, Al-Rabeah AM, Hajjeh R, Mustafa T, Fatani A, Al-Bassam T, Badukhan A, Turkistani A, Makki S, Al-Hamdan N, Al-Jeffri M, Al Mazrou Y, Perkins BA, Popovic T, Mayer LW, Rosenstein NE. 2003. Serogroup W-135 meningococcal disease during the Hajj, 2000. Emerg Infect Dis 9:665–671. doi:10.3201/eid0906.020565. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources